NHBE cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
HIC2
|
ENSG00000169635.5 | HIC ZBTB transcriptional repressor 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HIC2 | hg19_v2_chr22_+_21771656_21771693 | 0.24 | 6.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_+_131409476 | 3.68 |
ENST00000296871.2
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage) |
chr1_-_47655686 | 2.55 |
ENST00000294338.2
|
PDZK1IP1
|
PDZK1 interacting protein 1 |
chr17_+_37821593 | 2.31 |
ENST00000578283.1
|
TCAP
|
titin-cap |
chr15_+_31658349 | 1.85 |
ENST00000558844.1
|
KLF13
|
Kruppel-like factor 13 |
chr1_-_153363452 | 1.53 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
chr19_-_45579762 | 1.50 |
ENST00000303809.2
|
ZNF296
|
zinc finger protein 296 |
chr22_-_37415475 | 1.42 |
ENST00000403892.3
ENST00000249042.3 ENST00000438203.1 |
TST
|
thiosulfate sulfurtransferase (rhodanese) |
chr12_-_7245125 | 1.33 |
ENST00000542285.1
ENST00000540610.1 |
C1R
|
complement component 1, r subcomponent |
chr17_-_42994283 | 1.29 |
ENST00000593179.1
|
GFAP
|
glial fibrillary acidic protein |
chr16_-_18441131 | 1.25 |
ENST00000339303.5
|
NPIPA8
|
nuclear pore complex interacting protein family, member A8 |
chr12_-_7245018 | 1.21 |
ENST00000543835.1
ENST00000535233.2 |
C1R
|
complement component 1, r subcomponent |
chr10_+_26986582 | 1.20 |
ENST00000376215.5
ENST00000376203.5 |
PDSS1
|
prenyl (decaprenyl) diphosphate synthase, subunit 1 |
chr12_-_127630534 | 1.18 |
ENST00000535022.1
|
RP11-575F12.2
|
RP11-575F12.2 |
chr12_-_7244469 | 1.17 |
ENST00000538050.1
ENST00000536053.2 |
C1R
|
complement component 1, r subcomponent |
chr3_+_10206545 | 1.14 |
ENST00000256458.4
|
IRAK2
|
interleukin-1 receptor-associated kinase 2 |
chr9_-_35658007 | 1.13 |
ENST00000602361.1
|
RMRP
|
RNA component of mitochondrial RNA processing endoribonuclease |
chr12_-_58159361 | 1.12 |
ENST00000546567.1
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1 |
chr6_-_30712313 | 1.08 |
ENST00000376377.2
ENST00000259874.5 |
IER3
|
immediate early response 3 |
chr5_-_139726181 | 1.06 |
ENST00000507104.1
ENST00000230990.6 |
HBEGF
|
heparin-binding EGF-like growth factor |
chr19_+_35741466 | 1.05 |
ENST00000599658.1
|
LSR
|
lipolysis stimulated lipoprotein receptor |
chr19_+_7743387 | 1.04 |
ENST00000597959.1
|
CTD-3214H19.16
|
CTD-3214H19.16 |
chr3_-_4793274 | 1.04 |
ENST00000414938.1
|
EGOT
|
eosinophil granule ontogeny transcript (non-protein coding) |
chr14_+_103592636 | 1.04 |
ENST00000333007.1
|
TNFAIP2
|
tumor necrosis factor, alpha-induced protein 2 |
chr17_-_6616678 | 1.03 |
ENST00000381074.4
ENST00000293800.6 ENST00000572352.1 ENST00000576323.1 ENST00000573648.1 |
SLC13A5
|
solute carrier family 13 (sodium-dependent citrate transporter), member 5 |
chr1_+_152691998 | 1.03 |
ENST00000368775.2
|
C1orf68
|
chromosome 1 open reading frame 68 |
chr11_+_118826999 | 1.03 |
ENST00000264031.2
|
UPK2
|
uroplakin 2 |
chr3_-_178865747 | 1.02 |
ENST00000435560.1
|
RP11-360P21.2
|
RP11-360P21.2 |
chr19_+_10381769 | 1.02 |
ENST00000423829.2
ENST00000588645.1 |
ICAM1
|
intercellular adhesion molecule 1 |
chr16_+_88704978 | 1.02 |
ENST00000244241.4
|
IL17C
|
interleukin 17C |
chr12_-_7245080 | 1.00 |
ENST00000541042.1
ENST00000540242.1 |
C1R
|
complement component 1, r subcomponent |
chr1_-_149814478 | 0.98 |
ENST00000369161.3
|
HIST2H2AA3
|
histone cluster 2, H2aa3 |
chr19_+_54372877 | 0.98 |
ENST00000414489.1
|
MYADM
|
myeloid-associated differentiation marker |
chr19_+_18530146 | 0.98 |
ENST00000348495.6
ENST00000270061.7 |
SSBP4
|
single stranded DNA binding protein 4 |
chr9_-_33402506 | 0.97 |
ENST00000377425.4
ENST00000537089.1 ENST00000297988.1 ENST00000539936.1 ENST00000541274.1 |
AQP7
|
aquaporin 7 |
chr5_+_3596168 | 0.97 |
ENST00000302006.3
|
IRX1
|
iroquois homeobox 1 |
chr3_+_32148106 | 0.96 |
ENST00000425459.1
ENST00000431009.1 |
GPD1L
|
glycerol-3-phosphate dehydrogenase 1-like |
chr8_-_73793975 | 0.95 |
ENST00000523881.1
|
RP11-1145L24.1
|
RP11-1145L24.1 |
chr5_-_159739483 | 0.95 |
ENST00000519673.1
ENST00000541762.1 |
CCNJL
|
cyclin J-like |
chr19_-_14682838 | 0.92 |
ENST00000215565.2
|
NDUFB7
|
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa |
chr11_+_64808675 | 0.90 |
ENST00000529996.1
|
SAC3D1
|
SAC3 domain containing 1 |
chr16_+_58497587 | 0.89 |
ENST00000569404.1
ENST00000569539.1 ENST00000564126.1 ENST00000565304.1 ENST00000567667.1 |
NDRG4
|
NDRG family member 4 |
chr5_-_159739532 | 0.89 |
ENST00000520748.1
ENST00000393977.3 ENST00000257536.7 |
CCNJL
|
cyclin J-like |
chr8_-_11324273 | 0.89 |
ENST00000284486.4
|
FAM167A
|
family with sequence similarity 167, member A |
chr19_-_42192189 | 0.89 |
ENST00000401731.1
ENST00000338196.4 ENST00000006724.3 |
CEACAM7
|
carcinoembryonic antigen-related cell adhesion molecule 7 |
chr2_+_37571717 | 0.89 |
ENST00000338415.3
ENST00000404976.1 |
QPCT
|
glutaminyl-peptide cyclotransferase |
chr22_+_31031639 | 0.88 |
ENST00000343605.4
ENST00000300385.8 |
SLC35E4
|
solute carrier family 35, member E4 |
chr19_-_13260992 | 0.86 |
ENST00000242770.5
ENST00000589083.1 ENST00000587230.1 |
STX10
|
syntaxin 10 |
chr9_-_130477912 | 0.85 |
ENST00000543175.1
|
PTRH1
|
peptidyl-tRNA hydrolase 1 homolog (S. cerevisiae) |
chr16_+_8736232 | 0.85 |
ENST00000562973.1
|
METTL22
|
methyltransferase like 22 |
chr6_-_34524049 | 0.84 |
ENST00000374037.3
|
SPDEF
|
SAM pointed domain containing ETS transcription factor |
chr11_+_61717279 | 0.84 |
ENST00000378043.4
|
BEST1
|
bestrophin 1 |
chr19_-_44174305 | 0.82 |
ENST00000601723.1
ENST00000339082.3 |
PLAUR
|
plasminogen activator, urokinase receptor |
chr9_-_139839064 | 0.82 |
ENST00000325285.3
ENST00000428398.1 |
FBXW5
|
F-box and WD repeat domain containing 5 |
chr11_+_61717336 | 0.80 |
ENST00000378042.3
|
BEST1
|
bestrophin 1 |
chr19_-_17516449 | 0.80 |
ENST00000252593.6
|
BST2
|
bone marrow stromal cell antigen 2 |
chr15_+_75498739 | 0.79 |
ENST00000565074.1
|
C15orf39
|
chromosome 15 open reading frame 39 |
chr14_-_94856951 | 0.79 |
ENST00000553327.1
ENST00000556955.1 ENST00000557118.1 ENST00000440909.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr1_+_948803 | 0.79 |
ENST00000379389.4
|
ISG15
|
ISG15 ubiquitin-like modifier |
chr11_+_65686952 | 0.79 |
ENST00000527119.1
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr19_-_44174330 | 0.79 |
ENST00000340093.3
|
PLAUR
|
plasminogen activator, urokinase receptor |
chr6_+_138188351 | 0.78 |
ENST00000421450.1
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr17_+_73455788 | 0.77 |
ENST00000581519.1
|
KIAA0195
|
KIAA0195 |
chr6_-_133035185 | 0.77 |
ENST00000367928.4
|
VNN1
|
vanin 1 |
chr19_+_17326521 | 0.77 |
ENST00000593597.1
|
USE1
|
unconventional SNARE in the ER 1 homolog (S. cerevisiae) |
chr17_-_73874654 | 0.76 |
ENST00000254816.2
|
TRIM47
|
tripartite motif containing 47 |
chr20_-_44516256 | 0.76 |
ENST00000372519.3
|
SPATA25
|
spermatogenesis associated 25 |
chr17_-_45918539 | 0.75 |
ENST00000584123.1
ENST00000578323.1 ENST00000407215.3 ENST00000290216.9 |
SCRN2
|
secernin 2 |
chr19_+_50887585 | 0.75 |
ENST00000440232.2
ENST00000601098.1 ENST00000599857.1 ENST00000593887.1 |
POLD1
|
polymerase (DNA directed), delta 1, catalytic subunit |
chr7_+_79763271 | 0.75 |
ENST00000442586.1
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
chr1_+_205473720 | 0.75 |
ENST00000429964.2
ENST00000506784.1 ENST00000360066.2 |
CDK18
|
cyclin-dependent kinase 18 |
chr2_+_27282134 | 0.75 |
ENST00000441931.1
|
AGBL5
|
ATP/GTP binding protein-like 5 |
chr15_+_91445448 | 0.74 |
ENST00000558290.1
ENST00000558853.1 ENST00000559999.1 |
MAN2A2
|
mannosidase, alpha, class 2A, member 2 |
chr4_+_8201091 | 0.74 |
ENST00000382521.3
ENST00000245105.3 ENST00000457650.2 ENST00000539824.1 |
SH3TC1
|
SH3 domain and tetratricopeptide repeats 1 |
chr11_-_8739383 | 0.73 |
ENST00000531060.1
|
ST5
|
suppression of tumorigenicity 5 |
chr8_-_145086922 | 0.73 |
ENST00000530478.1
|
PARP10
|
poly (ADP-ribose) polymerase family, member 10 |
chr16_-_54963026 | 0.72 |
ENST00000560208.1
ENST00000557792.1 |
CRNDE
|
colorectal neoplasia differentially expressed (non-protein coding) |
chr10_+_48247669 | 0.70 |
ENST00000457620.1
|
FAM25G
|
family with sequence similarity 25, member G |
chr17_+_73717516 | 0.70 |
ENST00000200181.3
ENST00000339591.3 |
ITGB4
|
integrin, beta 4 |
chr22_+_37956453 | 0.70 |
ENST00000249014.4
|
CDC42EP1
|
CDC42 effector protein (Rho GTPase binding) 1 |
chr19_-_7698599 | 0.70 |
ENST00000311069.5
|
PCP2
|
Purkinje cell protein 2 |
chr18_-_61311485 | 0.70 |
ENST00000436264.1
ENST00000356424.6 ENST00000341074.5 |
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4 |
chr7_+_76109827 | 0.69 |
ENST00000446820.2
|
DTX2
|
deltex homolog 2 (Drosophila) |
chr21_-_46359760 | 0.69 |
ENST00000330551.3
ENST00000397841.1 ENST00000380070.4 |
C21orf67
|
chromosome 21 open reading frame 67 |
chr9_-_32573130 | 0.69 |
ENST00000350021.2
ENST00000379847.3 |
NDUFB6
|
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa |
chr1_-_173638976 | 0.69 |
ENST00000333279.2
|
ANKRD45
|
ankyrin repeat domain 45 |
chr11_-_104480019 | 0.68 |
ENST00000536529.1
ENST00000545630.1 ENST00000538641.1 |
RP11-886D15.1
|
RP11-886D15.1 |
chr8_-_125869733 | 0.68 |
ENST00000533496.1
|
RP11-1082L8.3
|
RP11-1082L8.3 |
chr15_+_89182178 | 0.68 |
ENST00000559876.1
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr11_+_64052692 | 0.68 |
ENST00000377702.4
|
GPR137
|
G protein-coupled receptor 137 |
chr2_+_232573208 | 0.67 |
ENST00000409115.3
|
PTMA
|
prothymosin, alpha |
chr18_+_66382428 | 0.67 |
ENST00000578970.1
ENST00000582371.1 ENST00000584775.1 |
CCDC102B
|
coiled-coil domain containing 102B |
chr19_-_58485895 | 0.67 |
ENST00000314391.3
|
C19orf18
|
chromosome 19 open reading frame 18 |
chr22_+_37415676 | 0.66 |
ENST00000401419.3
|
MPST
|
mercaptopyruvate sulfurtransferase |
chr16_+_28857916 | 0.66 |
ENST00000563591.1
|
SH2B1
|
SH2B adaptor protein 1 |
chr6_+_12958137 | 0.66 |
ENST00000457702.2
ENST00000379345.2 |
PHACTR1
|
phosphatase and actin regulator 1 |
chr1_+_205473865 | 0.66 |
ENST00000506215.1
ENST00000419301.1 |
CDK18
|
cyclin-dependent kinase 18 |
chr17_-_74276438 | 0.66 |
ENST00000532549.1
|
QRICH2
|
glutamine rich 2 |
chr11_+_94038759 | 0.65 |
ENST00000440961.2
ENST00000328458.4 |
FOLR4
|
folate receptor 4, delta (putative) |
chr16_-_2168079 | 0.65 |
ENST00000488185.2
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant) |
chr2_+_232573222 | 0.64 |
ENST00000341369.7
ENST00000409683.1 |
PTMA
|
prothymosin, alpha |
chr2_+_232572361 | 0.64 |
ENST00000409321.1
|
PTMA
|
prothymosin, alpha |
chr19_+_29704142 | 0.64 |
ENST00000587859.1
ENST00000590607.1 |
CTB-32O4.2
|
CTB-32O4.2 |
chr11_-_64885111 | 0.64 |
ENST00000528598.1
ENST00000310597.4 |
ZNHIT2
|
zinc finger, HIT-type containing 2 |
chr12_+_6554021 | 0.64 |
ENST00000266557.3
|
CD27
|
CD27 molecule |
chr1_-_27693349 | 0.64 |
ENST00000374040.3
ENST00000357582.2 ENST00000493901.1 |
MAP3K6
|
mitogen-activated protein kinase kinase kinase 6 |
chr19_+_17413663 | 0.64 |
ENST00000594999.1
|
MRPL34
|
mitochondrial ribosomal protein L34 |
chr17_+_73717407 | 0.63 |
ENST00000579662.1
|
ITGB4
|
integrin, beta 4 |
chr19_+_532049 | 0.63 |
ENST00000606136.1
|
CDC34
|
cell division cycle 34 |
chr15_+_89182156 | 0.63 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr17_+_73717551 | 0.62 |
ENST00000450894.3
|
ITGB4
|
integrin, beta 4 |
chr9_+_131102925 | 0.62 |
ENST00000372870.1
ENST00000300456.4 |
SLC27A4
|
solute carrier family 27 (fatty acid transporter), member 4 |
chr19_-_17414179 | 0.62 |
ENST00000594194.1
ENST00000247706.3 |
ABHD8
|
abhydrolase domain containing 8 |
chr11_-_61658853 | 0.62 |
ENST00000525588.1
ENST00000540820.1 |
FADS3
|
fatty acid desaturase 3 |
chr3_+_184080790 | 0.61 |
ENST00000430783.1
|
POLR2H
|
polymerase (RNA) II (DNA directed) polypeptide H |
chr15_-_64338521 | 0.60 |
ENST00000457488.1
ENST00000558069.1 |
DAPK2
|
death-associated protein kinase 2 |
chr19_+_39647271 | 0.60 |
ENST00000599657.1
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4 |
chr11_-_66496655 | 0.60 |
ENST00000527010.1
|
SPTBN2
|
spectrin, beta, non-erythrocytic 2 |
chr19_+_56159509 | 0.60 |
ENST00000586790.1
ENST00000591578.1 ENST00000588740.1 |
CCDC106
|
coiled-coil domain containing 106 |
chr11_-_61659006 | 0.59 |
ENST00000278829.2
|
FADS3
|
fatty acid desaturase 3 |
chr19_-_59023348 | 0.59 |
ENST00000601355.1
ENST00000263093.2 |
SLC27A5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr4_+_6717842 | 0.59 |
ENST00000320776.3
|
BLOC1S4
|
biogenesis of lysosomal organelles complex-1, subunit 4, cappuccino |
chr6_+_30951487 | 0.59 |
ENST00000486149.2
ENST00000376296.3 |
MUC21
|
mucin 21, cell surface associated |
chr5_-_147286065 | 0.58 |
ENST00000318315.4
ENST00000515291.1 |
C5orf46
|
chromosome 5 open reading frame 46 |
chr6_-_34524093 | 0.58 |
ENST00000544425.1
|
SPDEF
|
SAM pointed domain containing ETS transcription factor |
chr1_+_152748848 | 0.57 |
ENST00000334371.2
|
LCE1F
|
late cornified envelope 1F |
chr1_-_3566627 | 0.57 |
ENST00000419924.2
ENST00000270708.7 |
WRAP73
|
WD repeat containing, antisense to TP73 |
chr17_-_2615031 | 0.57 |
ENST00000576885.1
ENST00000574426.2 |
CLUH
|
clustered mitochondria (cluA/CLU1) homolog |
chr3_+_50388126 | 0.56 |
ENST00000425346.1
ENST00000424512.1 ENST00000232508.5 ENST00000418577.1 ENST00000606589.1 |
CYB561D2
XXcos-LUCA11.5
|
cytochrome b561 family, member D2 Uncharacterized protein |
chr16_-_80838160 | 0.56 |
ENST00000562812.1
ENST00000563890.1 ENST00000566173.1 |
CDYL2
|
chromodomain protein, Y-like 2 |
chr6_+_138188551 | 0.56 |
ENST00000237289.4
ENST00000433680.1 |
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr6_-_3227877 | 0.56 |
ENST00000259818.7
|
TUBB2B
|
tubulin, beta 2B class IIb |
chr11_+_65627974 | 0.56 |
ENST00000525768.1
|
MUS81
|
MUS81 structure-specific endonuclease subunit |
chr9_-_131486367 | 0.56 |
ENST00000372663.4
ENST00000406904.2 ENST00000452105.1 ENST00000372672.2 ENST00000372667.5 |
ZDHHC12
|
zinc finger, DHHC-type containing 12 |
chr10_-_5541525 | 0.56 |
ENST00000380332.3
|
CALML5
|
calmodulin-like 5 |
chr11_+_65082289 | 0.56 |
ENST00000279249.2
|
CDC42EP2
|
CDC42 effector protein (Rho GTPase binding) 2 |
chr17_+_42427826 | 0.56 |
ENST00000586443.1
|
GRN
|
granulin |
chr7_+_76101379 | 0.56 |
ENST00000429179.1
|
DTX2
|
deltex homolog 2 (Drosophila) |
chr16_+_67312049 | 0.55 |
ENST00000565899.1
|
PLEKHG4
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 4 |
chr22_+_37415776 | 0.55 |
ENST00000341116.3
ENST00000429360.2 ENST00000404393.1 |
MPST
|
mercaptopyruvate sulfurtransferase |
chr1_-_33642151 | 0.55 |
ENST00000543586.1
|
TRIM62
|
tripartite motif containing 62 |
chr19_+_40871734 | 0.55 |
ENST00000359274.5
|
PLD3
|
phospholipase D family, member 3 |
chr16_+_1832902 | 0.55 |
ENST00000262302.9
ENST00000563136.1 ENST00000565987.1 ENST00000543305.1 ENST00000568287.1 ENST00000565134.1 |
NUBP2
|
nucleotide binding protein 2 |
chr20_+_62367989 | 0.55 |
ENST00000309546.3
|
LIME1
|
Lck interacting transmembrane adaptor 1 |
chr12_-_7245152 | 0.55 |
ENST00000542220.2
|
C1R
|
complement component 1, r subcomponent |
chr21_+_33784957 | 0.54 |
ENST00000401402.3
ENST00000382699.3 |
EVA1C
|
eva-1 homolog C (C. elegans) |
chr21_+_34804479 | 0.54 |
ENST00000421802.1
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1) |
chr11_-_62473776 | 0.54 |
ENST00000278893.7
ENST00000407022.3 ENST00000421906.1 |
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin) |
chr17_-_19651598 | 0.54 |
ENST00000570414.1
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1 |
chr12_+_113860160 | 0.54 |
ENST00000553248.1
ENST00000345635.4 ENST00000547802.1 |
SDSL
|
serine dehydratase-like |
chr5_-_150473127 | 0.53 |
ENST00000521001.1
|
TNIP1
|
TNFAIP3 interacting protein 1 |
chr19_+_54609230 | 0.53 |
ENST00000420296.1
|
NDUFA3
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa |
chr2_+_219187871 | 0.53 |
ENST00000258362.3
|
PNKD
|
paroxysmal nonkinesigenic dyskinesia |
chr1_+_152881014 | 0.53 |
ENST00000368764.3
ENST00000392667.2 |
IVL
|
involucrin |
chr4_+_3465027 | 0.53 |
ENST00000389653.2
ENST00000507039.1 ENST00000340083.5 |
DOK7
|
docking protein 7 |
chr3_-_50340996 | 0.53 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
chrX_+_149531606 | 0.52 |
ENST00000432680.2
|
MAMLD1
|
mastermind-like domain containing 1 |
chr16_+_56642489 | 0.52 |
ENST00000561491.1
|
MT2A
|
metallothionein 2A |
chr19_+_38397839 | 0.52 |
ENST00000222345.6
|
SIPA1L3
|
signal-induced proliferation-associated 1 like 3 |
chr6_-_112080256 | 0.52 |
ENST00000462856.2
ENST00000229471.4 |
FYN
|
FYN oncogene related to SRC, FGR, YES |
chr14_-_101295407 | 0.52 |
ENST00000596284.1
|
AL117190.2
|
AL117190.2 |
chr17_-_78194147 | 0.52 |
ENST00000534910.1
ENST00000326317.6 |
SGSH
|
N-sulfoglucosamine sulfohydrolase |
chr20_-_43743790 | 0.52 |
ENST00000307971.4
ENST00000372789.4 |
WFDC5
|
WAP four-disulfide core domain 5 |
chr17_-_79481666 | 0.52 |
ENST00000575659.1
|
ACTG1
|
actin, gamma 1 |
chr22_-_36850991 | 0.52 |
ENST00000442579.1
|
RP5-1119A7.14
|
RP5-1119A7.14 |
chr3_+_126707437 | 0.52 |
ENST00000393409.2
ENST00000251772.4 |
PLXNA1
|
plexin A1 |
chr6_-_31938700 | 0.52 |
ENST00000495340.1
|
DXO
|
decapping exoribonuclease |
chr11_+_124735282 | 0.51 |
ENST00000397801.1
|
ROBO3
|
roundabout, axon guidance receptor, homolog 3 (Drosophila) |
chr12_+_6493199 | 0.51 |
ENST00000228918.4
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3) |
chr19_-_6057282 | 0.51 |
ENST00000592281.1
|
RFX2
|
regulatory factor X, 2 (influences HLA class II expression) |
chr12_-_3862245 | 0.51 |
ENST00000252322.1
ENST00000440314.2 |
EFCAB4B
|
EF-hand calcium binding domain 4B |
chr19_-_6333614 | 0.51 |
ENST00000301452.4
|
ACER1
|
alkaline ceramidase 1 |
chr1_+_201592013 | 0.51 |
ENST00000593583.1
|
AC096677.1
|
Uncharacterized protein ENSP00000471857 |
chr17_+_73997419 | 0.51 |
ENST00000425876.2
|
CDK3
|
cyclin-dependent kinase 3 |
chr1_+_152975488 | 0.51 |
ENST00000542696.1
|
SPRR3
|
small proline-rich protein 3 |
chr1_+_40420802 | 0.51 |
ENST00000372811.5
ENST00000420632.2 ENST00000434861.1 ENST00000372809.5 |
MFSD2A
|
major facilitator superfamily domain containing 2A |
chr17_+_25958174 | 0.51 |
ENST00000313648.6
ENST00000577392.1 ENST00000584661.1 ENST00000413914.2 |
LGALS9
|
lectin, galactoside-binding, soluble, 9 |
chr7_+_150758642 | 0.50 |
ENST00000488420.1
|
SLC4A2
|
solute carrier family 4 (anion exchanger), member 2 |
chr16_+_811073 | 0.50 |
ENST00000382862.3
ENST00000563651.1 |
MSLN
|
mesothelin |
chr10_+_81891416 | 0.50 |
ENST00000372270.2
|
PLAC9
|
placenta-specific 9 |
chr17_+_27895609 | 0.50 |
ENST00000581411.2
ENST00000301057.7 |
TP53I13
|
tumor protein p53 inducible protein 13 |
chr16_+_810728 | 0.50 |
ENST00000563941.1
ENST00000545450.2 ENST00000566549.1 |
MSLN
|
mesothelin |
chr17_+_75396637 | 0.50 |
ENST00000590825.1
|
SEPT9
|
septin 9 |
chr11_+_64808368 | 0.50 |
ENST00000531072.1
ENST00000398846.1 |
SAC3D1
|
SAC3 domain containing 1 |
chr3_-_129035120 | 0.50 |
ENST00000333762.4
|
H1FX
|
H1 histone family, member X |
chr12_+_6419877 | 0.50 |
ENST00000536531.1
|
PLEKHG6
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 6 |
chr8_-_145060593 | 0.49 |
ENST00000313059.5
ENST00000524918.1 ENST00000313028.7 ENST00000525773.1 |
PARP10
|
poly (ADP-ribose) polymerase family, member 10 |
chr11_+_66624527 | 0.49 |
ENST00000393952.3
|
LRFN4
|
leucine rich repeat and fibronectin type III domain containing 4 |
chrX_+_133930798 | 0.49 |
ENST00000414371.2
|
FAM122C
|
family with sequence similarity 122C |
chr7_+_73245193 | 0.49 |
ENST00000340958.2
|
CLDN4
|
claudin 4 |
chr11_-_2162162 | 0.49 |
ENST00000381389.1
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr12_+_6493319 | 0.49 |
ENST00000536876.1
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3) |
chr5_-_176889381 | 0.49 |
ENST00000393563.4
ENST00000512501.1 |
DBN1
|
drebrin 1 |
chr17_+_40440481 | 0.49 |
ENST00000590726.2
ENST00000452307.2 ENST00000444283.1 ENST00000588868.1 |
STAT5A
|
signal transducer and activator of transcription 5A |
chr7_-_76955563 | 0.48 |
ENST00000441833.2
|
GSAP
|
gamma-secretase activating protein |
chrX_-_84363974 | 0.48 |
ENST00000395409.3
ENST00000332921.5 ENST00000509231.1 |
SATL1
|
spermidine/spermine N1-acetyl transferase-like 1 |
chr19_-_1650666 | 0.48 |
ENST00000588136.1
|
TCF3
|
transcription factor 3 |
chr1_+_6640046 | 0.48 |
ENST00000319084.5
ENST00000435905.1 |
ZBTB48
|
zinc finger and BTB domain containing 48 |
chr17_+_7533439 | 0.48 |
ENST00000441599.2
ENST00000380450.4 ENST00000416273.3 ENST00000575903.1 ENST00000576830.1 ENST00000571153.1 ENST00000575618.1 ENST00000576152.1 |
SHBG
|
sex hormone-binding globulin |
chr19_-_41903161 | 0.48 |
ENST00000602129.1
ENST00000593771.1 ENST00000596905.1 ENST00000221233.4 |
EXOSC5
|
exosome component 5 |
chr17_+_7239821 | 0.48 |
ENST00000158762.3
ENST00000570457.2 |
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.7 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.8 | 2.3 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.7 | 3.4 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.6 | 1.7 | GO:0070429 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of osteoclast proliferation(GO:0090291) negative regulation of CD40 signaling pathway(GO:2000349) |
0.4 | 1.2 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.4 | 1.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 1.0 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.3 | 1.2 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.3 | 1.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.3 | 1.1 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
0.3 | 0.8 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
0.2 | 1.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 1.0 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.2 | 1.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) lobar bronchus epithelium development(GO:0060481) |
0.2 | 0.9 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.2 | 0.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 0.7 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 1.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.6 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.2 | 1.6 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.2 | 1.1 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.2 | 0.5 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.2 | 1.0 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.2 | 0.2 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
0.2 | 1.0 | GO:0097368 | membrane to membrane docking(GO:0022614) establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 0.5 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) natural killer cell tolerance induction(GO:0002519) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
0.2 | 0.7 | GO:0043375 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.2 | 0.8 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.2 | 0.8 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) peptidyl-glutamine modification(GO:0018199) isopeptide cross-linking(GO:0018262) |
0.2 | 0.6 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 0.5 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.2 | 0.5 | GO:0018016 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.2 | 0.6 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.2 | 0.3 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
0.2 | 0.6 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
0.2 | 0.5 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) regulation of G-protein coupled receptor internalization(GO:1904020) |
0.2 | 0.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.3 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 2.5 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 2.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 1.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.7 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.1 | 0.3 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.1 | 0.4 | GO:1901899 | positive regulation of relaxation of muscle(GO:1901079) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.1 | 0.9 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 1.1 | GO:0043585 | nose morphogenesis(GO:0043585) |
0.1 | 1.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.8 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.1 | 0.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.6 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.4 | GO:0015840 | urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
0.1 | 1.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.4 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.1 | 0.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.5 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.1 | 0.5 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.1 | 0.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.4 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.1 | 1.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.2 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.1 | 0.8 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.1 | 0.4 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.1 | 1.2 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.3 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) negative regulation of calcium-transporting ATPase activity(GO:1901895) |
0.1 | 0.4 | GO:0044691 | tooth eruption(GO:0044691) |
0.1 | 2.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.4 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.1 | 0.3 | GO:1903572 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.1 | 0.5 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.1 | 0.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.6 | GO:1903401 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
0.1 | 0.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.7 | GO:0019075 | virus maturation(GO:0019075) |
0.1 | 0.1 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.1 | 0.4 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.1 | 0.3 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.1 | 0.8 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.3 | GO:0031247 | actin rod assembly(GO:0031247) |
0.1 | 1.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.3 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.4 | GO:1904457 | beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
0.1 | 0.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.9 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 0.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.5 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.7 | GO:0015793 | glycerol transport(GO:0015793) |
0.1 | 0.7 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 1.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.3 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
0.1 | 0.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.2 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.1 | 0.2 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.1 | 0.4 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.1 | 0.2 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.1 | 0.3 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.2 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.1 | 0.1 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.1 | 0.5 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.1 | 0.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.2 | GO:0038162 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) erythropoietin-mediated signaling pathway(GO:0038162) |
0.1 | 0.8 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.1 | 0.2 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.1 | 0.4 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.1 | 0.3 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.1 | 4.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.3 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.1 | 0.3 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.1 | 0.7 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.1 | 0.4 | GO:0032899 | regulation of neurotrophin production(GO:0032899) |
0.1 | 0.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.2 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.1 | 0.4 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.1 | 0.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 0.2 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 0.2 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.1 | 0.8 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.1 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.2 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.1 | 0.2 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
0.1 | 0.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.3 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 0.3 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.1 | 0.3 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
0.1 | 0.7 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 0.2 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
0.1 | 0.5 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.1 | 0.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.1 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.1 | 0.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.2 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.1 | 0.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.7 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 2.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.2 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.1 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.7 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.2 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
0.1 | 0.2 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.1 | 1.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.2 | GO:0048242 | regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) epinephrine secretion(GO:0048242) |
0.1 | 0.7 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.3 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.2 | GO:1902824 | cleavage furrow ingression(GO:0036090) positive regulation of late endosome to lysosome transport(GO:1902824) |
0.1 | 0.2 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.2 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.1 | 0.8 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.9 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.2 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.3 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.1 | 0.2 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 1.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.3 | GO:0033603 | postganglionic parasympathetic fiber development(GO:0021784) positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.1 | 0.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.2 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.9 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.9 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.3 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.2 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.7 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.3 | GO:0060611 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
0.1 | 0.4 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 0.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.1 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.1 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.2 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.2 | GO:0001300 | chronological cell aging(GO:0001300) |
0.1 | 0.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.5 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.3 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.1 | 0.2 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 | 0.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.3 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.1 | 0.5 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.4 | GO:0045007 | depurination(GO:0045007) |
0.1 | 0.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 1.4 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.2 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.1 | 1.2 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.1 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.3 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.0 | 0.6 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.3 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.0 | 0.5 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.4 | GO:1904879 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 | 0.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.0 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.0 | 0.1 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.0 | 0.2 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.0 | 0.4 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.2 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.0 | 0.3 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.1 | GO:1901656 | glycoside transport(GO:1901656) |
0.0 | 0.1 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.0 | 0.2 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.0 | 0.6 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.0 | 0.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.5 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.0 | 0.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.9 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.2 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.0 | 0.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.3 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.0 | 0.0 | GO:0032618 | interleukin-15 production(GO:0032618) |
0.0 | 0.2 | GO:0046075 | dTTP metabolic process(GO:0046075) |
0.0 | 0.5 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.3 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 0.0 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.0 | 0.3 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.0 | 0.3 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.0 | 0.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.0 | 0.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.7 | GO:0060872 | semicircular canal development(GO:0060872) |
0.0 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 1.5 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.0 | 0.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.0 | 0.3 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.6 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.1 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.0 | 0.2 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
0.0 | 0.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.2 | GO:0016598 | protein arginylation(GO:0016598) |
0.0 | 0.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.0 | 0.2 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.1 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.0 | 1.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 1.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 1.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.2 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.0 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.7 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 0.1 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.0 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.0 | 2.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.3 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) negative regulation of response to cytokine stimulus(GO:0060761) |
0.0 | 0.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.1 | GO:0072007 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.0 | 0.1 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
0.0 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.0 | 0.5 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.0 | 0.2 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.0 | 0.4 | GO:0003360 | brainstem development(GO:0003360) |
0.0 | 0.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.4 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.0 | 0.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.3 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.0 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.0 | 0.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.0 | 0.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 1.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.2 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
0.0 | 0.3 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.0 | 0.3 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.1 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.0 | 0.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.0 | 0.2 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.0 | 0.3 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.0 | 0.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.1 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.0 | 0.2 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.0 | 0.3 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.1 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.0 | 0.1 | GO:0035936 | testosterone secretion(GO:0035936) regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
0.0 | 0.2 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.2 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.0 | 0.8 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.0 | 0.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.0 | 0.5 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.2 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.0 | 0.7 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 | 0.4 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.2 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.0 | 0.2 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.0 | 0.1 | GO:0051604 | protein maturation(GO:0051604) |
0.0 | 0.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 2.8 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.5 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.0 | 0.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.3 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 1.5 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.1 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
0.0 | 0.6 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.3 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.0 | 0.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 0.2 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.1 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.0 | 0.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.1 | GO:0048627 | myoblast development(GO:0048627) |
0.0 | 0.4 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0070101 | positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
0.0 | 0.3 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.0 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
0.0 | 0.1 | GO:0036034 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.0 | 0.1 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.0 | 0.1 | GO:0036292 | DNA rewinding(GO:0036292) |
0.0 | 0.2 | GO:0051344 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.3 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.4 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.0 | 1.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.0 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.0 | 0.6 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.0 | 0.3 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.0 | 1.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.2 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.0 | 0.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.1 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
0.0 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.2 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.0 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.0 | 0.4 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.2 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.0 | 0.1 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.0 | 0.3 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.0 | 0.2 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
0.0 | 0.1 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.0 | 0.2 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.1 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) regulation of positive thymic T cell selection(GO:1902232) |
0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.0 | 0.5 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.0 | 0.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.1 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.0 | 0.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.4 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.2 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.2 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.2 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.6 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.2 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.1 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.0 | 0.4 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.1 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.1 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.5 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.2 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.0 | 0.0 | GO:1903243 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
0.0 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.4 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.2 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.0 | 0.2 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.0 | 1.9 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.0 | 0.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.3 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.0 | 0.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.1 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.0 | 0.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.0 | 0.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.2 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.0 | 0.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.0 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.0 | 0.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.0 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.0 | 0.1 | GO:0060525 | prostate glandular acinus development(GO:0060525) prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.0 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.0 | 0.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.0 | 0.2 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.0 | 0.1 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.0 | 0.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 0.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.1 | GO:0071486 | cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.0 | 0.0 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.3 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.0 | 0.1 | GO:0097338 | response to clozapine(GO:0097338) |
0.0 | 0.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.1 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.4 | GO:0097320 | membrane tubulation(GO:0097320) |
0.0 | 0.3 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.0 | 0.1 | GO:1902402 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.0 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.5 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.3 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.4 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.2 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.0 | 0.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.7 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.0 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.0 | 0.2 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.0 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.0 | 0.0 | GO:0009644 | response to high light intensity(GO:0009644) |
0.0 | 0.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.3 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.1 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.0 | 0.2 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.3 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.0 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.0 | 0.3 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.0 | 0.2 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 1.3 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.0 | 0.4 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.0 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.0 | 0.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.0 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.0 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.4 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.8 | GO:0048814 | regulation of dendrite morphogenesis(GO:0048814) |
0.0 | 0.1 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.1 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 0.1 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.0 | 0.0 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.3 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.4 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.4 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.3 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.0 | GO:0003095 | pressure natriuresis(GO:0003095) |
0.0 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.9 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.1 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.9 | GO:0002133 | polycystin complex(GO:0002133) |
0.2 | 0.5 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.2 | 0.5 | GO:0097444 | spine apparatus(GO:0097444) |
0.2 | 0.9 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 0.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.9 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 1.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.8 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.5 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 0.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.5 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
0.1 | 0.3 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.1 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 0.6 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.1 | 1.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.1 | 0.3 | GO:0043257 | laminin-8 complex(GO:0043257) |
0.1 | 0.3 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.5 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.1 | 0.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.3 | GO:0045160 | myosin I complex(GO:0045160) |
0.1 | 0.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.2 | GO:1990032 | parallel fiber(GO:1990032) |
0.1 | 0.4 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.2 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.3 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.7 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.1 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.1 | 0.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.2 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 1.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.9 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.3 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 0.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.5 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.0 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.0 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.3 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.0 | 0.3 | GO:0034448 | EGO complex(GO:0034448) |
0.0 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
0.0 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0044753 | amphisome(GO:0044753) |
0.0 | 0.1 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.0 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.3 | GO:0032010 | phagolysosome(GO:0032010) |
0.0 | 0.2 | GO:0097060 | syn |